Neobe Therapeutics Ltd
13146056 · Active
Company details
- Type
- Private Limited Company
- Incorporated
- 2021-01-20
- Country of origin
- United Kingdom
Accounts & filings
- Accounts last filed
- 2024-12-31 · TOTAL EXEMPTION FULL
- Next accounts due
- 2026-09-30 in 100 days
- Confirmation statement
- last made up 2026-01-20 · next due 2027-02-03
Registered office
Salisbury HouseStation Road
Cambridge
Cb1 2la
Peer comparison
Compared against 72 UK companies in SIC 72110 (Research and experimental development on biotechnology) within the Small bracket (£100k–£1M net assets).
See where this company ranks
Included with the £1 AI analysis unlock — one payment unlocks both for this company. Yours forever.
Based on this company's latest filed accounts (to Dec 2025) · Balance sheet only — small-company filing, no public profit & loss.
Unlock for £1Compares this company to 72 UK peers in Small bracket, by net assets, turnover, profitability, and more.
Financial health
Derived from the filed accounts to Dec 2025. Figures only — not advice.
See this company's financial health
£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.
Based on this company's latest filed accounts (to Dec 2025) · Balance sheet only — small-company filing, no public profit & loss.
Unlock for £1Ratios and signals derived from this company's filed Companies House figures only.
Accounts
Based on this company's latest filed accounts (to Dec 2025) · Balance sheet only — small-company filing, no public profit & loss.
| Year ending | Dec 2025 | Dec 2024 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Fixed assets |
£5,890
↓32.1%
|
£8,673
↑26.9%
|
£6,834
|
£0
|
— |
| Current assets |
£267,907
↓67.4%
|
£821,889
↓30.0%
|
£1,174,379
↑522.2%
|
£188,744
↑178.7%
|
£67,712
|
| Cash |
£37,097
↓91.6%
|
£440,326
↓57.6%
|
£1,037,336
↑702.5%
|
£129,271
↑232.8%
|
£38,844
|
| Net current assets |
£222,024
↓67.6%
|
£684,828
↓39.1%
|
£1,123,886
↑3573.2%
|
£30,597
↓49.2%
|
£60,233
|
| Net assets |
£227,914
↓67.1%
|
£693,501
↓38.7%
|
£1,130,720
↑3595.5%
|
£30,597
↓49.2%
|
£60,233
|
| Equity |
£227,914
↓67.1%
|
£693,501
↓38.7%
|
£1,130,720
↑3595.5%
|
£30,597
↓49.2%
|
£60,233
|
| Other | |||||
| Average employees |
8
↑33.3%
|
6
↑20.0%
|
5
↑25.0%
|
4
↑33.3%
|
3
|
Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.
Industry (SIC codes)
Officers (8)
- Deep Science Ventures Limited · Corporate Director appointed 2025-12-19
- Juniarsih, Imelda, Dr · Director appointed 2023-12-21
- Wolf, Julie, Dr · Director appointed 2023-12-20
- Blundy, Keith Stuart · Director appointed 2023-03-15
- Soulier, Annelise Juliette, Dr. · Director appointed 2021-01-20
- Vaz De Almada Correa De Sampaio, Pedro, Dr. · Director appointed 2021-01-20
- Fletcher, Laura Margaret, Dr · Director appointed 2021-04-14 resigned 2025-12-19
- Hammond, Mark William Jonathan Charles, Dr · Director appointed 2021-01-20 resigned 2021-04-14
People with significant control (3)
-
Dr. Annelise Juliette Soulier Ceased 2024-01-21Individual Psc · French · resident in England · born 5/1979 · notified 2021-01-20Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors
-
Dr. Pedro Vaz De Almada Correa De Sampaio Ceased 2024-01-21Individual Psc · Portuguese · resident in United Kingdom · born 8/1984 · notified 2021-01-20Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors
-
Persons-With-Significant-Control-Statement ActivePersons With Significant Control Statement · notified 2024-01-21
Mortgages & charges (1)
1 outstanding
-
Held by Sprk Capital LimitedCreated 2026-04-30
Recent filings (15)
- 2026-05-14 Total-exemption-full accounts AA Accounts
- 2026-04-30 Mortgage create with deed with charge number charge creation date MR01 Mortgage
- 2026-02-03 Confirmation statement (with updates) CS01 Confirmation statement
- 2026-01-30 Director details changed CH01 Officers
- 2025-12-19 Appoint corporate director company with name date AP02 Officers
- 2025-12-19 Termination director company with name termination date TM01 Officers
- 2025-08-29 Total-exemption-full accounts AA Accounts
- 2025-01-21 Confirmation statement (no updates) CS01 Confirmation statement
- 2024-10-22 Change account reference date company current shortened AA01 Accounts
- 2024-10-22 Total-exemption-full accounts AA Accounts
- 2024-01-29 Confirmation statement (with updates) CS01 Confirmation statement
- 2024-01-26 Memorandum and articles (paper) MA Incorporation
- 2024-01-26 Notification of a person with significant control statement PSC08 PSC
- 2024-01-26 Cessation of a person with significant control PSC07 PSC
- 2024-01-26 Cessation of a person with significant control PSC07 PSC
Showing the 15 most recent filings. View full filing history at Companies House.
Source: Companies House register